Summary
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limitations such as hepatic toxicity and extra-hepatic progression.
With the aim of overcoming these limitations, a phase II trial was designed to assess the efficacy and tolerability of a hybrid chemotherapy regimen with systemic infusion of oxaliplatin and folinic acid associated with intra-arterial 5-fluorouracil.
Thirty-nine patients with colorectal liver metastases were recruited. The median age was 59 years, 30 patients (77%) had synchronous metastases, and half of the patients were chemo-naive. A total of 313 chemotherapy cycles were administered (median number 8). Treatment was well tolerated and hepatic toxicity negligible. Out of 34 evaluable patients an ORR of 41%. was observed. Eight patients (21%) underwent radical liver surgery. The median time to progression (TTP) was 10 months (range 2–63) and the median overall survival (OS) 21 months (range 6–63). Extra-hepatic progression was observed in six patients.
Our results suggest that this regimen is active even if technical complications are frequent. Our aim to reduce hepatic toxicity and extra-hepatic progression was reached.
Similar content being viewed by others
References
Skibber JM, Minsky BD, Hoff PM (2001) Cancer of the colon. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer—principles & practice of oncology, 6th edn. Lippincott Willimas & Wilkins, Philadelphia, pp 1216–1271
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947
Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047
Ensminger WD (2002) Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29:119–125
Chan R, Kerr D (2004) Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003. Curr Opin Oncol 16:378–384
Lorenz M, Müller H-H (2000) For the German Cooperative Group on the liver metastases: randomized, multicenter trial of fluoruracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18:243–254
Kerr DJ, McArdle CS, Ledermann J, Taylor I, Sherlock DJ, Schlag PM, Buckels J, Mayer D, Cain D, Stephens RJ (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361:368–373
Cohen AD, Kemeny NE (2003) An update on hepatic arterial infusion chemotherapy for colorectal cancer. The Oncologist 8:553–566
Chamberlain RS (2004) Laparoscopic placement of hepatic arterial pumps: a true advance or a lot effort for a procedure with diminishing role? Ann Surg Oncol 11:558–559
Urbach DR, Herron DM, Khajanchee YS, Swanstrom LL, Hansen PD (2001) Laparoscopic hepatic artery infusion pump placement. Arch Surg 136:700–704
Oberfield RA, Sampson E, Heatley J (2004) Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the Lahey Clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement. Am J Clin Oncol 27:376–383
Kemeny N, Gonen M, Sullivan D, Schwartz L, Benedetti F, Saltz L, Stockman J, Fong Y, Jarnagin W, Bertino J, Tong W, Paty P (2001) Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 19:2687–2695
Kemeny N, Jarnagin W, Gonen M, Stockman J, Blumgart L, Sperber D, Hummer A, Fong Y (2003) Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 21:3303–3309
Kern W, Beckert B, Lang N, Waggershauser T, Braess J, Schalhorn A, Hiddemann W (2000) Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal, cancer: role of carcino-embryonic antigen in assessment of response. Anticancer Res 20:4973–4976
Kemeny N, Jarnagin W, Paty P, Gonen M, Schwartz L, Morse M, Leonard G, D’Angelica M, DeMatteo R, Blumgart L, Fong Y (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888–4896
Simon R (1989) Optimal two-stage designs for phase II clinical trials. Controlled Clin Trials 10:1–10
Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9:193–200
Haller DG (2000) Waiting for the definitive trial of hepatic arterial chemotherapy from colorectal cancer. J Clin Oncol 18:239–242
Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M (2005) Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the Gastrointestinal Group of the Fédération Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23:4881–4887
Dizon DS, Kemeny NE (2002) Intrahepatic arterial infusion of chemotherapy: clinical results. Semin Oncol 29:126–135
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carnaghi, C., Santoro, A., Rimassa, L. et al. The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study. Invest New Drugs 25, 479–485 (2007). https://doi.org/10.1007/s10637-007-9048-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-007-9048-5